4.2 Article Proceedings Paper

Linking Amyloid-beta and Tau: Amyloid-beta Induced Synaptic Dysfunction via Local Wreckage of the Neuronal Cytoskeleton

期刊

NEURODEGENERATIVE DISEASES
卷 10, 期 1-4, 页码 64-72

出版社

KARGER
DOI: 10.1159/000332816

关键词

Amyloid-beta; Tau; Microtubule; Synapse; Spine; Alzheimer's disease; Calcium; Neurofilament

向作者/读者索取更多资源

Background: In Alzheimer's disease (AD), amyloid-beta (A beta) is the major component of extracellular plaques, whereas the microtubule-associated protein tau forms the main component of intracellular tangles. In contrast to frontotemporal dementias and other neurodegenerative diseases, both proteins form pathological aggregates and are considered key players for the development of AD. However, the connection between A beta and tau and the functional loss of neurons and synapses, which ultimately lead to cognitive impairments, is still not well understood. Objectives: Making use of primary neurons exposed to A beta oligomers, we sought to determine how tau mediates the A beta-induced neuronal dysfunction. Additionally, we asked how the microtubule cytoskeleton is involved in the combined A beta and tau toxicity. Methods: We exposed mature primary rat neurons with developed synapses to A beta oligomers and used immunofluorescence and electron microscopy to investigate tau, actin, neurofilament and microtuble cytoskeleton changes. Results: A beta oligomers preferentially associate with synapses, notably dendritic spines, throughout the neuronal cell culture. As a consequence, endogenous tau gets missorted from the axonal into the somatodendritic compartment in a subset of cells. These missorted cells also display missorting of neurofilaments, and a dramatic loss of microtubules, which can be prevented by the microtubule stabilizer taxol. Conclusions: A beta causes tau missorting, loss of neuronal cell polarity and loss of dendritic microtubules. This in turn leads to impaired organelle/mitochondria transport, whereby synapses cannot be maintained properly and eventually decay. The data support the view that the microtubule cytoskeleton is a valid therapeutic target in AD. Copyright (C) 2011 S. Karger AG, Basel

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据